End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
6.87
CNY
|
-1.72%
|
|
-9.72%
|
+0.44%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,341
|
4,395
|
3,545
|
6,221
|
7,062
|
6,122
|
Enterprise Value (EV)
1 |
3,881
|
3,492
|
3,189
|
4,897
|
5,811
|
5,560
|
P/E ratio
|
7.35
x
|
27.3
x
|
-14.1
x
|
10.2
x
|
6.36
x
|
5.85
x
|
Yield
|
4.12%
|
1.83%
|
-
|
2.3%
|
1.27%
|
1.46%
|
Capitalization / Revenue
|
0.82
x
|
0.95
x
|
0.96
x
|
1.06
x
|
0.73
x
|
0.72
x
|
EV / Revenue
|
0.74
x
|
0.76
x
|
0.86
x
|
0.84
x
|
0.6
x
|
0.65
x
|
EV / EBITDA
|
5.05
x
|
7.48
x
|
-142
x
|
4.55
x
|
3.64
x
|
3.48
x
|
EV / FCF
|
7.6
x
|
4.12
x
|
-114
x
|
3.98
x
|
5.89
x
|
-17.3
x
|
FCF Yield
|
13.2%
|
24.3%
|
-0.88%
|
25.1%
|
17%
|
-5.79%
|
Price to Book
|
1.29
x
|
1.31
x
|
1.16
x
|
1.75
x
|
1.7
x
|
1.18
x
|
Nbr of stocks (in thousands)
|
895,092
|
895,092
|
895,092
|
895,092
|
895,092
|
895,092
|
Reference price
2 |
4.850
|
4.910
|
3.960
|
6.950
|
7.890
|
6.840
|
Announcement Date
|
4/16/19
|
4/1/20
|
3/29/21
|
3/24/22
|
3/23/23
|
3/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5,263
|
4,621
|
3,688
|
5,851
|
9,712
|
8,528
|
EBITDA
1 |
769.2
|
466.8
|
-22.42
|
1,077
|
1,598
|
1,598
|
EBIT
1 |
554.7
|
182
|
-332.9
|
809.5
|
1,297
|
1,296
|
Operating Margin
|
10.54%
|
3.94%
|
-9.03%
|
13.84%
|
13.35%
|
15.19%
|
Earnings before Tax (EBT)
1 |
618.2
|
216.7
|
-298.5
|
830.5
|
1,436
|
1,350
|
Net income
1 |
586.5
|
163
|
-252.2
|
604.7
|
1,108
|
1,044
|
Net margin
|
11.15%
|
3.53%
|
-6.84%
|
10.34%
|
11.41%
|
12.24%
|
EPS
2 |
0.6600
|
0.1800
|
-0.2800
|
0.6800
|
1.240
|
1.170
|
Free Cash Flow
1 |
510.3
|
847.8
|
-27.91
|
1,231
|
986.3
|
-321.7
|
FCF margin
|
9.7%
|
18.35%
|
-0.76%
|
21.04%
|
10.15%
|
-3.77%
|
FCF Conversion (EBITDA)
|
66.34%
|
181.63%
|
-
|
114.26%
|
61.73%
|
-
|
FCF Conversion (Net income)
|
87.01%
|
519.99%
|
-
|
203.58%
|
89.01%
|
-
|
Dividend per Share
2 |
0.2000
|
0.0900
|
-
|
0.1600
|
0.1000
|
0.1000
|
Announcement Date
|
4/16/19
|
4/1/20
|
3/29/21
|
3/24/22
|
3/23/23
|
3/21/24
|
Fiscal Period: December |
2022 Q2
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
477.4
|
Net margin
|
-
|
EPS
2 |
0.5300
|
Dividend per Share
|
-
|
Announcement Date
|
8/8/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
460
|
903
|
356
|
1,324
|
1,251
|
562
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
510
|
848
|
-27.9
|
1,231
|
986
|
-322
|
ROE (net income / shareholders' equity)
|
19.1%
|
4.9%
|
-7.94%
|
18.5%
|
27.5%
|
22.5%
|
ROA (Net income/ Total Assets)
|
7.8%
|
2.5%
|
-4.72%
|
10.2%
|
12.3%
|
10.8%
|
Assets
1 |
7,520
|
6,522
|
5,349
|
5,903
|
8,984
|
9,654
|
Book Value Per Share
2 |
3.770
|
3.760
|
3.400
|
3.960
|
4.640
|
5.790
|
Cash Flow per Share
2 |
0.5100
|
1.010
|
0.4000
|
1.500
|
1.440
|
1.070
|
Capex
1 |
80.5
|
33.8
|
23.9
|
29.1
|
132
|
185
|
Capex / Sales
|
1.53%
|
0.73%
|
0.65%
|
0.5%
|
1.36%
|
2.17%
|
Announcement Date
|
4/16/19
|
4/1/20
|
3/29/21
|
3/24/22
|
3/23/23
|
3/21/24
|
|
1st Jan change
|
Capi.
|
---|
| +0.44% | 849M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|